Trial reportJMIR mHealth and uHealth2022
Effect of an Integrative Mobile Health Intervention in Patients With Hypertension and Diabetes: Crossover Study.
Trial report in JMIR mHealth and uHealth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 30 citations in OpenAlex.
- Effects of WeChat-based telehealth on patients reported outcomes of hypertension: a randomized controlled trial.Scientific reports · 2025Trial
- Calorie-Counting Apps for Monitoring and Managing Calorie Intake in Adults Living With Weight-Related Chronic Diseases: Decade-Long Scoping Review (2013-2024).JMIR mHealth and uHealth · 2026Article
- Mobile App-based mHealth Interventions and Cardiovascular Risk Factors in Patients with Type 2 Diabetes: A Narrative Review.Current cardiology reports · 2026Review
- Integrated Management Strategies for Diabetes Mellitus and Hypertension: A Systematic Review.Cureus · 2026Review
- Digital Health Interventions to Support Chronic Disease Management: Systematic Scoping Review.JMIR mHealth and uHealth · 2026Article
- Article
- User experiences with a mobile health app for self-management of diabetes and hypertension in Ghana: a qualitative study.Annals of medicine · 2025Article
- The Use of Artificial Intelligence (AI) to Support Dietetic Practice Across Primary Care: A Scoping Review of the Literature.Nutrients · 2025Article
- Adherence-based experiences with a personalized self-care program for type 2 diabetes in South Korea: a mixed-methods study.Journal of Korean biological nursing science · 2025Article
- Implementation of hospital-initiated complex interventions for adult people with multiple long-term conditions: a scoping review.BMC health services research · 2025Article
- Wearable Devices for Supporting Chronic Disease Self-Management: Scoping Review.Interactive journal of medical research · 2024Article
- Participatory Development of an Integrated, eHealth-Supported, Educational Care Pathway (Diabetes Box) for People With Type 2 Diabetes: Development and Usability Study.JMIR human factors · 2024Article
- Self-Care Management, Patient Education, and Nursing Support in Patients with Diabetes and Hypertension.Galen medical journal · 2024Review
- Effect of intelligent hypertension management system on blood pressure: protocol for a randomised controlled multicentre trial.BMJ open · 2023Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity, hypertension, and type 2 diabetes mellitus (T2DM) are worldwide epidemics that inflict burdens on both public health and health care costs. Self-management plays an important role in the proper management of these 3 chronic diseases, and in this context, mobile health (mHealth) can be a cost-effective self-management tool.
objectiveThe aim of this pilot study is to evaluate the effects of an integrative mHealth approach for obesity, hypertension, and T2DM on body fat, blood pressure, and blood glucose levels and demonstrate the clinical outcomes. The participants were patients aged 40 to 70 years who were treated for T2DM (hemoglobin A
methodsThis pilot study was performed using a controlled, randomized, 3-month, 2-period crossover design. A total of 37 participants were recruited from 2 university hospitals in South Korea. Integrative mHealth comprised 4 parts: self-measuring home devices for monitoring blood glucose and blood pressure; 2 smartphone apps, where one gathered lifestyle data, giving them feedback with health information, and the other provided drug information and reminders of the medication schedule; unmanned kiosks for official measurement of blood pressure and body composition; and web-based access to participants' health information.
resultsData from the 32 participants were analyzed. Their mean HbA
conclusionsAlthough smartphone apps can influence body fat and blood glucose levels, they have failed to show clinical improvement. A higher input rate of taking medicine was related to significantly lower body fat mass and HbA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.